Literature DB >> 16399370

Inborn errors of biliary canalicular transport systems.

Ralf Kubitz1, Verena Keitel, Dieter Häussinger.   

Abstract

Cholestatic syndromes are inborn or acquired disorders of bile formation. In recent years, several inherited cholestatic syndromes were characterized at the molecular level: progressive familial intrahepatic cholestasis (PFIC) and benign recurrent intrahepatic cholestasis (BRIC). Both PFIC and BRIC were divided phenotypically in distinct subtypes; however, at the genotype level, these clinical entities overlap. PFIC starts in early childhood and progresses toward liver cirrhosis, which often requires liver transplantation within the first decade of life. The diagnosis of PFIC is usually made on the basis of clinical and laboratory findings but needs to be confirmed by genetic and histological analysis. Only recently was it recognized that BRIC, which was estimated as a milder form of PFIC-1, may be caused by more than one gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16399370     DOI: 10.1016/S0076-6879(05)00031-5

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  7 in total

1.  Inherited disorders of bile Acid transport or synthesis.

Authors:  William F Balistreri
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-05

Review 2.  Drug transporters in pharmacokinetics.

Authors:  Ernst Petzinger; Joachim Geyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-11       Impact factor: 3.000

3.  Early Diagnosis of ABCB11 Spectrum Liver Disorders by Next Generation Sequencing.

Authors:  Su Jeong Lee; Jung Eun Kim; Byung-Ho Choe; An Na Seo; Han-Ik Bae; Su-Kyeong Hwang
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2017-06-28

Review 4.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 5.  Biomarkers, metabonomics, and drug development: can inborn errors of metabolism help in understanding drug toxicity?

Authors:  Subrahmanyam Vangala; Alfred Tonelli
Journal:  AAPS J       Date:  2007-07-20       Impact factor: 4.009

Review 6.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

7.  miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity.

Authors:  Ryan M Allen; Tyler J Marquart; Carolyn J Albert; Frederick J Suchy; David Q-H Wang; Meenakshisundaram Ananthanarayanan; David A Ford; Angel Baldán
Journal:  EMBO Mol Med       Date:  2012-07-05       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.